CD40LG and in situ carcinoma: However, the finding that anti-EBV IgM antibodies were detected primarily in CIS patients suggests that EBV reactivation could be a precipitating factor in the first but not subsequent demyelinating episodes, though this would need to be confirmed in a larger study.